Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 4Biliary Tract Neoplasms 3Neoplasms 2Klatskin Tumor 2Esophageal Neoplasms 2Jaundice, Obstructive 1Gastric Outlet Obstruction 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Self Expandable Metallic Stents × Clear all
NCT03259763 2026-03-06

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction

Johns Hopkins University

Phase NA Completed
112 enrolled
Gastrointestinal

Neoplasms, Gastric Outlet Obstruction

NCT01894763 2013-07-10

Prospective Comparison of Large vs. Small Diameter Esophageal Stents for Palliation of Malignant Dysphagia

Mayo Clinic

Phase 1 Completed
100 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡